Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Clinical trial NCT03875729 · COMPLETED

Trial details

NCT number: NCT03875729
Sponsor: Provention Bio, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2019-04-05
Primary completion: 2023-05-01
Enrollment: 328

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.